Resmed (ASX: RMD) plans to consolidate its brand portfolio over the next couple of years, the company said in a statement Tuesday.
The initiative will include an education program for primary care physicians to promote early sleep apnea diagnosis and a sleep health awareness push in Asia Pacific and Europe, the company said.
Resmed's shares fell past 5% in recent Wednesday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.